search
Back to results

Intensive Insulin Treatment and Ischemic Foot Ulcer

Primary Purpose

Ischemic Foot Ulcer

Status
Completed
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Intensified insulin treatment
Standard treatment
Sponsored by
Karolinska Institutet
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Ischemic Foot Ulcer focused on measuring HbA1c, Iontophoresis, Intensified insulin treatment, Ischemic foot ulcer, Type 1 diabetes

Eligibility Criteria

18 Years - 50 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

Born 1930 or later, Type 1 diabetes appearing at age 30 or earlier and with insulin dependency within 1 year from diagnosis, no known abuse of alcohol or drugs, non-prolipherative retinopathy of any degree present, no previous photocoagulation, normal serum creatinine, unsatsifactory blood glucose control according to the physician in charge of the patients.

Exclusion Criteria:

Any history or ongoing ischemic foot ulcer,or peripheral artery disease,or osteoartropathy.

Sites / Locations

  • Karolinska Institutet, Department of Clinical Science and Education, Södersjukhuset
  • Karolinska Institutet, Division of Internal Medicine Södersjukhuset AB

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Active Comparator

No Intervention

Arm Label

Intensified insulin treatment

Standard treatment

Healthy controls

Arm Description

Basal (Monotard) insulin; ones a day Bolus (Actrapid) insulin; thrice a day

Mixed Insulin (2-3 times a day)

These people were solely controls for the iontophoresis method used in the study. With no intervention or follow-up-

Outcomes

Primary Outcome Measures

Ischemic Foot Ulcer
The study outcome is the first hospitalization for ischemic foot ulcer, defined by the ICD-10 discharge code

Secondary Outcome Measures

Full Information

First Posted
October 4, 2013
Last Updated
September 28, 2020
Sponsor
Karolinska Institutet
search

1. Study Identification

Unique Protocol Identification Number
NCT01957930
Brief Title
Intensive Insulin Treatment and Ischemic Foot Ulcer
Official Title
Intensified Insulin Treatment and Skin Microcirculation; Its Relation to Ischemic Foot Ulcer in Patients With Type 1 Diabetes Mellitus: A Long-term Follow-up Study
Study Type
Interventional

2. Study Status

Record Verification Date
September 2020
Overall Recruitment Status
Completed
Study Start Date
January 1984 (undefined)
Primary Completion Date
December 2011 (Actual)
Study Completion Date
June 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Karolinska Institutet

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
We aim to investigate the relationship between skin microvascular function and the first hospitalization for ischemic foot ulcer in patients with type 1 diabetes former randomized during 7.5 years to intensified conventional insulin treatment (ICT) compared to standard insulin treatment (ST).
Detailed Description
The Stockholm Diabetes Intervention Study (SDIS) aimed to determine whether intensified insulin treatment were feasible and led to less serious diabetic complications. 102 patients with type 1 diabetes mellitus were randomiz (October 1982 to March 1984) to intensified conventional treatment (ICT; n=48) or standard treatment (ST; n=54). The randomized SDIS study lasted for 7.5 years, whereas 96 patients were fully evaluated. Thereafter patients were assigned to their regular clinical visits. In the present study, 96 patients from the SDIS study were asked to participate in current study and to investigate their skin microcirculation, in which 72 patients agreed (ICT; n=35 vs. ST; n=37). Also, nineteen healthy subjects participated as controls for the method of iontophoresis, with no intention to be followed-up. Exclusions criteria were; any history or ongoing ischemic foot ulcer or peripheral artery disease or osteoartropathy. The iontophoresis investigation took place 5.5 years ± 2 months, after the primary randomization ceased (7.5 years). All participants (except the control subjects) were then followed-up until first time hospitalization for ischemic foot ulcer or until 31 december 2011.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ischemic Foot Ulcer
Keywords
HbA1c, Iontophoresis, Intensified insulin treatment, Ischemic foot ulcer, Type 1 diabetes

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
91 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Intensified insulin treatment
Arm Type
Experimental
Arm Description
Basal (Monotard) insulin; ones a day Bolus (Actrapid) insulin; thrice a day
Arm Title
Standard treatment
Arm Type
Active Comparator
Arm Description
Mixed Insulin (2-3 times a day)
Arm Title
Healthy controls
Arm Type
No Intervention
Arm Description
These people were solely controls for the iontophoresis method used in the study. With no intervention or follow-up-
Intervention Type
Drug
Intervention Name(s)
Intensified insulin treatment
Other Intervention Name(s)
Monotard; Actrapid
Intervention Description
The treatment regimen of the intensified treatment group consisted of individual education and then continuous tutoring with frequent face-to-face and telephone contact.
Intervention Type
Drug
Intervention Name(s)
Standard treatment
Other Intervention Name(s)
Premixed Insulin
Intervention Description
Patients continuing with routine diabetes care (insulin treatment), visiting physician every four months
Primary Outcome Measure Information:
Title
Ischemic Foot Ulcer
Description
The study outcome is the first hospitalization for ischemic foot ulcer, defined by the ICD-10 discharge code
Time Frame
Until hospitalization for ischemic foot ulcer or until 31 December 2011
Other Pre-specified Outcome Measures:
Title
Microvascular Endothelial Function
Description
Microvascular function is measured with a single point iontophoresis after stimulation with topically applied acetylcholine (ACh) [endothelial-dependent], sodium nitroprusside (SNP) [endothelial-independent], and capsaicin [C-nociceptive dependent] vasculature response.
Time Frame
7 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Born 1930 or later, Type 1 diabetes appearing at age 30 or earlier and with insulin dependency within 1 year from diagnosis, no known abuse of alcohol or drugs, non-prolipherative retinopathy of any degree present, no previous photocoagulation, normal serum creatinine, unsatsifactory blood glucose control according to the physician in charge of the patients. Exclusion Criteria: Any history or ongoing ischemic foot ulcer,or peripheral artery disease,or osteoartropathy.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Thomas Nyström, MD
Organizational Affiliation
Karolinska Institutet
Official's Role
Principal Investigator
Facility Information:
Facility Name
Karolinska Institutet, Department of Clinical Science and Education, Södersjukhuset
City
Stockholm
ZIP/Postal Code
118 83
Country
Sweden
Facility Name
Karolinska Institutet, Division of Internal Medicine Södersjukhuset AB
City
Stockholm
ZIP/Postal Code
118 83
Country
Sweden

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
3048052
Citation
Reichard P, Britz A, Cars I, Nilsson BY, Sobocinsky-Olsson B, Rosenqvist U. The Stockholm Diabetes Intervention Study (SDIS): 18 months' results. Acta Med Scand. 1988;224(2):115-22. doi: 10.1111/j.0954-6820.1988.tb16748.x.
Results Reference
background
PubMed Identifier
8147960
Citation
Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med. 1993 Jul 29;329(5):304-9. doi: 10.1056/NEJM199307293290502.
Results Reference
background
PubMed Identifier
24802206
Citation
Rathsman B, Jensen-Urstad K, Nystrom T. Intensified insulin treatment is associated with improvement in skin microcirculation and ischaemic foot ulcer in patients with type 1 diabetes mellitus: a long-term follow-up study. Diabetologia. 2014 Aug;57(8):1703-10. doi: 10.1007/s00125-014-3248-2. Epub 2014 May 7.
Results Reference
derived

Learn more about this trial

Intensive Insulin Treatment and Ischemic Foot Ulcer

We'll reach out to this number within 24 hrs